Gruppenleiter
© CMCB
Group Leader
NameProf. Ezio Bonifacio
Präklinische Stammzellentherapie/ Diabetes
Eine verschlüsselte E-Mail über das SecureMail-Portal versenden (nur für TUD-externe Personen).
Prof. Ezio Bonifacio is Chair for "preclinical stem cell therapy and diabetes" at the Faculty of Medicine of the TU Dresden.
Education
|
1992 |
PhD in Pathology (University of Western Australia) |
|
1988 |
Bachelor of Applied Science (Curtin University, Western Australia) |
Positions held
| since 2019 | Co-Director, Dresden Genome Center Next Generation Sequencing Competence Center |
|
2016 - 2018 |
Director of the CRTD |
|
since 2007 |
Professor, Center for Regenerative Therapies, Technische Universität Dresden, Germany |
|
2001 - 2007 |
Director, Telethon-JDRF Center for Beta Cell Replacement, San Raffaele Scientific Institute, Milan, Italy |
|
1999 |
von Humboldt fellow, Institute of Diabetes Research, Munich, Germany |
|
1996 - 2007 |
Head of Unit, Immunology of Diabetes, San Raffaele Scientific Institute, Milan, Italy |
|
1993 - 1996 |
Assistente Ricercatore, Department of Medicine, San Raffaele Scientific Institute, Milan, Italy |
|
1991 - 1992 |
Lecturer, Department of Immunology, London Hospital Medical College |
|
1989 - 1991 |
JDF Research Fellow, Department of Immunology, Middlesex Hospital Medical School, London |
|
1987 - 1988 |
Visiting Research Fellow, Department of Immunology, Middlesex Hospital Medical School, London |
|
1983 - 1989 |
Senior Technologist, Department of Clinical Immunology, QEII Med Centre, Western Australia |
|
1981 - 1983 |
Medical Technologist, Department of Clinical Immunology, QEII Med Centre, Western Australia |
|
1979 - 1980 |
Research Assistant, Department of Pathology, University of Western Australia |